(Q40432410)

20 September 2017

1 reference

title

Clinical investigation of 11 beta-hydroxysteroid dehydrogenase (English)

1 reference

20 September 2017

Clinical investigation of 11β-hydroxysteroid dehydrogenase (English)

1 reference

https://api.crossref.org/works/10.3109/07435809509030454

27 May 2024

1 reference

B. R. Walker

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7588401

27 May 2024

R. Best

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7588401

27 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7588401

27 May 2024

publication date

1 February 1995

1 reference

full work available at URL

20 September 2017

http://www.tandfonline.com/doi/pdf/10.3109/07435809509030454

1 reference

https://api.crossref.org/works/10.3109/07435809509030454

27 May 2024

1 reference

20 September 2017

volume

21

1 reference

20 September 2017

issue

1-2

1 reference

20 September 2017

page(s)

379-387

1 reference

A Syndrome of Apparent Mineralocorticoid Excess Associated with Defects in the Peripheral Metabolism of Cortisol*

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07435809509030454

Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435809509030454

Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11 beta-hydroxysteroid dehydrogenase activity in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435809509030454

Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435809509030454

Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435809509030454

11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435809509030454

Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435809509030454

Synthesis of a deuterium-labeled cortisol for the study of its rate of 11 beta-hydroxy dehydrogenation in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435809509030454

Bile acids and their amidates inhibit 11 beta-hydroxysteroid dehydrogenase obtained from rat kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435809509030454

Possible endogenous regulators of steroid inactivating enzymes and glucocorticoid-induced Na+ retention.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435809509030454

Detection of glycyrrhetinic acid-like factors (GALFs) in human urine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435809509030454

Regulation of 11 beta-hydroxysteroid dehydrogenase activity by the hypothalamic-pituitary-adrenal axis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435809509030454

LOCALISATION OF 11β-HYDROXYSTEROID DEHYDROGENASE—TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTOR

21 January 2018

6

1 reference

https://api.crossref.org/works/10.3109/07435809509030454

Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome

27 May 2024

11

1 reference

https://api.crossref.org/works/10.3109/07435809509030454

Gene expression of 11 beta-hydroxysteroid dehydrogenase in the mesenteric arteries of genetically hypertensive rats

27 May 2024

14

1 reference

https://api.crossref.org/works/10.3109/07435809509030454

11 beta-Hydroxysteroid dehydrogenase activity in mesenteric arteries of spontaneously hypertensive rats

27 May 2024

15

1 reference

https://api.crossref.org/works/10.3109/07435809509030454

Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man

27 May 2024

19

1 reference

https://api.crossref.org/works/10.3109/07435809509030454

Deficient inactivation of cortisol by 11 beta-hydroxysteroid dehydrogenase in essential hypertension

27 May 2024

20

1 reference

https://api.crossref.org/works/10.3109/07435809509030454

Investigation of urinary steroid profiles as a diagnostic method in Cushing's syndrome

27 May 2024

22

1 reference

https://api.crossref.org/works/10.3109/07435809509030454

Plasma deoxycorticosterone in normal and abnormal pregnancy

27 May 2024

26

1 reference

https://api.crossref.org/works/10.3109/07435809509030454

Annals of clinical laboratory science

27 May 2024

30

23

456

Semafuko WE B

1993

1 reference

https://api.crossref.org/works/10.3109/07435809509030454

Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11 beta-hydroxysteroid dehydrogenase

27 May 2024

34

1 reference

https://api.crossref.org/works/10.3109/07435809509030454

A new defect in the peripheral conversion of cortisone to cortisol

27 May 2024

36

1 reference

https://api.crossref.org/works/10.3109/07435809509030454

27 May 2024

Identifiers

1 reference

20 September 2017

1 reference